Strive Health Secures $550M to Advance AI and Expand Specialty Care

strive-health-secures-550m-to-advance-ai-and-specialty-care
Representational image

Strive Health, a leading value-based kidney care provider, has secured a total of $550 million in fresh funding. This includes $300 million in a Series D equity round and $250 million in debt financing. The company plans to use this capital to accelerate its investment in artificial intelligence tools and strengthen partnerships with payers and providers across the country.

High-Profile Investors Back Series D Round

New Enterprise Associates (NEA) led the equity funding, with continued support from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, and Redpoint. Several new institutional investors also joined the round, including funds and accounts managed by BlackRock affiliates. Meanwhile, Hercules Capital led the debt financing.

Notably, many of these same investors also participated in Strive’s $166 million Series C round in 2023, underscoring their ongoing confidence in the company’s model and mission.

Valuation Reaches $1.8 Billion

With this latest funding round, Strive Health has now raised $700 million to date, boosting its valuation to $1.8 billion. According to Fierce Healthcare, the funding marks a significant milestone as the company continues to scale nationally.

Also Read |  CBMR Celebrates 19th Foundation Day, Highlights Advances in Biomedical Research

Expanding Reach and Patient Impact

Strive Health now cares for more than 145,000 individuals with kidney disease and works with over 6,500 providers in all 50 states. In 2023 alone, the company supported 80,000 patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) across 30 states. Strive reports managing nearly $5 billion in annual medical spend.

The company also employs over 700 team members, up from previous years, reflecting its ongoing growth.

Integrating AI and Broadening Specialty Services

Founded in 2018, Strive has built an integrated care delivery model that leverages AI-powered, tech-enabled interventions and seamless coordination with local providers. This approach supports patients throughout their journey—from early-stage CKD to advanced ESRD.

In addition to kidney care, Strive has expanded into other high-cost specialties, including congestive heart failure.

Flexible Partnerships Across the Healthcare Landscape

Strive Health collaborates with a wide range of healthcare stakeholders, including commercial insurers, Medicare Advantage plans, health systems, and physicians. The company supports various value-based payment models, including full risk-based arrangements. Its customer base includes major organizations like Humana, Aetna, Oak Street Health, and several Blue Cross Blue Shield plans.

Also Read |  Spike in Respiratory Cases at AIIMS as Delhi’s Air Pollution Worsens